Sanofi Pasteur Hopes Work On Dengue Vaccine Will Inform Zika Research; Vaccine Candidate Possible By Next Year

Bloomberg Business: Sanofi’s Brandicourt Pushes for Speedy Zika Vaccine Development
“Sanofi Chief Executive Officer Olivier Brandicourt is pushing for speedy development of a Zika virus vaccine, building on the company’s success in bringing the first inoculation against dengue to market. Sanofi could start testing a vaccine candidate in people as early as next year, Brandicourt said during a press conference in Paris Tuesday…” (Torsoli, 2/9).

CNN: How and when will we get to a Zika vaccine?
“…Sanofi Pasteur said it hopes to use what it learned in those dengue trials to speed up their hunt for a Zika vaccine, but a ‘typical vaccine takes about 10 years to develop,’ said Nicholas Jackson, who heads up the effort. ‘We have a jump start here because we have experts in-house, technologies in-house; we have an infrastructure that we put in place around dengue vaccine we can tap into very quickly which will hopefully take off (time from) the typical timeline’…” (Christensen, 2/9).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.